Abstract:Regulation of neural stem cell number needs to be tightly controlled. Mutations affecting stem cells or progenitor cells may result in uncontrolled proliferation and ultimately cancer. A growing body of evidence suggests that this mechanism underlies the genesis of several brain tumors, e.g. gliomas. The most malignant form is called glioblastoma multiforme and unfortunately its prognosis remains poor. The concept of tumor-causing stem cell-like cells, also called cancer stem cells, in solid tumors has attracted a lot of interest over the last 5–10 years. A glioma-initiating cell bearing stem cell characteristics has been proposed as the origin of glioma, with the ability to seed new tumors through the capacity to evade chemotherapy and irradiation. This would be a unique feature for glioma-initiating cells, not shared by the bulk of tumor cells. Neural progenitors and glioma-initiating cells have several common traits, such as sustained proliferation and a highly efficient migratory capacity in the brain. There are similarities between then neurogenic niche where adult neural stem cells reside, and the tumorigenic niche. These include interactions with the extracellular matrix, and many of the matrix components are deregulated in glioma. The signaling pathways that are mutated in glioma are in general important neural stem cell pathways that regulate cell proliferation/self renewal, differentiation, migration and survival. Molecular changes in these pathways due to mutations are associated with brain tumor development and so present therapy targets. Novel molecular classification of glioblastoma gives hope for more stratified treatment, and we are hopefully on the threshold to patient-specific treatments which may finally change the outcome in this devastating disease.

Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells

The Pathobiology of Glioma Tumors

Meningioma: current updates on genetics, classification, and mouse modeling

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies

The neurobiology of gliomas: from cell biology to the development of therapeutic approaches

Advances in computational and translational approaches for malignant glioma

Common Denominators of Self-renewal and Malignancy in Neural Stem Cells and Glioma

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Glial Malignancies

Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer

Animal Models in Glioblastoma: Use in Biology and Developing Therapeutic Strategies

In vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes

Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?

Genetic and Epigenetic Determinants in Tumor Initiation and Progression of Glioblastoma

In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies

Genomic medicine advances for brain tumors

Molecular pathways in the formation of gliomas

The challenges and the promise of molecular targeted therapy in malignant gliomas.

Integrated Proteogenomics Uncover Mechanisms of Glioblastoma Evolution, Pointing to Novel Therapeutic Targets.